8th Pharmaron Symposium on Synthetic and Medicinal Chemistry

September 15, 2018 l Beijing Headquarters

• Dr. Michael Brands, Senior Vice President, Small Molecule Innovation, Bayer AG, Germany: Expanding the Chemical Space: Screening Library Development at Bayer 
• Dr. Chengyi Chen, Scientific Director, API Small Molecule Development Discovery, Johnson & Johnson, Switzerland: Synthesis of Heterocycles via Copper-catalyzed N-N Formation 
• Dr. Martin Eastgate, Head, Chemical Research-Chemical and Synthetic Development, Bristol-Myers Squibb, USA: Innovation in the Synthesis of Complex Pharmaceutical Compounds 
• Dr. Frank Narjes, Senior Principal Scientist, Medicinal Chemistry, AstraZeneca, Sweden: The Discovery of AZD0284: A Novel, Orally Bioavailable Inverse Agonist of the Nuclear Receptor ROR
• Prof. Larry Overman, Department of Chemistry, University of California, Irvine, CA, USA: Fragment Coupling with Carbon Radicals 
• Prof. Masakatsu Shibasaki, Chairman of Board of Directors, Microbial Chemistry Research Foundation, Japan: Recent Progress in Cooperative Asymmetric Catalysis 
• Dr. Jingjun Yin, Senior Principal Scientist, Department of Process Research & Development, MSD, USA: Making Better Drugs Faster, Cheaper and Greener: An Elbasvir/Ruzasvir Story 
• Dr. Wendy Young, Senior Vice President, Small Molecule Drug Discovery, Genentech, USA: Teamwork: Discovery and Development of Small Molecule Drug Candidates 
• Prof. Biao Yu, Deputy Director, Shanghai Institute of Organic Chemistry (SIOC), China : Chemical Synthesis of Complex Natural Glycosides of Biological Significance